Back to results
US 2026/0183396 A1Published application
Cxcr3 overexpression in car-nk cells primes migration/homing into the tumor microenvironment
AssigneeDana-Farber Cancer Institute, Inc.
InventorsErik H. KNELSON, Juan J. MIRET, Marco CAMPISI, David BARBIE, Patrick H. LIZOTTE, Mubin TARANNUM, Rizwan ROMEE, Cloud PAWELETZ
Life of this patent
Estimating the term…
Abstract
Disclosed are nucleic acid constructs encoding CXCR3 and a CAR and cells containing same for the treatment of cancers.
Claims22
A nucleic acid construct comprising:
- a first nucleic acid comprising a first promotor operably linked to a nucleic acid encoding a C—X—C Motif Chemokine Receptor 3 (CXCR3);
- and
- a second nucleic acid encoding a chimeric antigen receptor (CAR), wherein the CAR comprises a ligand binding domain comprising a single chain antibody fragment that binds an antigen on a tumor cell, a transmembrane domain, and an intracellular domain comprising a signaling domain.
Dependencies are inferred from the claim text.